Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nano-X Imaging (NNOX) EBITDA (2020 - 2025)

Nano-X Imaging filings provide 6 years of EBITDA readings, the most recent being -$33.4 million for Q4 2025.

  • On a quarterly basis, EBITDA fell 137.13% to -$33.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$75.0 million, a 40.98% decrease, with the full-year FY2025 number at -$75.0 million, down 40.98% from a year prior.
  • EBITDA hit -$33.4 million in Q4 2025 for Nano-X Imaging, down from -$13.7 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$9.9 million in Q4 2023 to a low of -$52.4 million in Q4 2022.
  • Median EBITDA over the past 5 years was -$13.9 million (2021), compared with a mean of -$18.2 million.
  • Biggest five-year swings in EBITDA: skyrocketed 81.08% in 2023 and later crashed 137.13% in 2025.
  • Nano-X Imaging's EBITDA stood at -$22.5 million in 2021, then plummeted by 133.17% to -$52.4 million in 2022, then skyrocketed by 81.08% to -$9.9 million in 2023, then plummeted by 42.06% to -$14.1 million in 2024, then crashed by 137.13% to -$33.4 million in 2025.
  • The last three reported values for EBITDA were -$33.4 million (Q4 2025), -$13.7 million (Q3 2025), and -$14.7 million (Q2 2025) per Business Quant data.